Endpoints News 生物医药· Kyle LaHucik·· 28 天前AI 评分26
Pathos AI 以 30 亿美元估值完成 2.37 亿美元 E 轮融资,与 BMS 达成神经领域合作
Pathos raises $237M at $3B valuation, signs Bristol Myers neuro partnership
AI 导读
AI 驱动的生物科技公司 Pathos AI 宣布以 30 亿美元估值完成 2.37 亿美元 E 轮融资。与此同时,该公司与 Bristol Myers 签署了神经领域的合作伙伴协议。这一融资与合作动向标志着其在人工智能药物发现领域的进一步扩张。
正文
AI-driven biotech Pathos AI has corralled a $237 million Series E at a $3 billion valuation, the New York-based company said on Wednesday.
The large …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news